Frequency Therapeutics Inc. Common Stock is a biotechnology company that develops therapies using its proprietary technology, Progenitor Cell Activation (PCA). Through advanced techniques, Frequency Therapeutics aims to regenerate targeted tissues and organs to treat a range of diseases and conditions.
Notification